No surgical procedures for morbid obesity received positive coverage decision in Norway

19

May 2022

In 2013, Norway established a framework, "New Method," for the introduction of innovations into the health care system through either a national or hospital-based health technology assessment. In this framework, all innovations should undergo HTA before being funded.

Surgery for morbid obesity has been evaluated within the "New Method" framework since 2019. In March 2022, the method assessment phase was completed, and the National Institute of Public Health (NIPH) report was published. The following surgical procedures were considered:

  • Adjustable gastric band (AGB);
  • Sleeve gastrectomy (SG);
  • Roux-en-Y gastric bypass (RYGB);
  • Distal Roux-en-Y gastric bypass (RYGB);
  • Biliopancreatic diversion with duodenal switch (BPD/DS);
  • Biliopancreatic diversion (BPD);
  • One-anastomosis gastric bypass (OAGB).

On April 25, 2022, the Decision Forum for "New Method" made the following conclusions:

  • No recommendation can be made for a preferred surgical procedure in the treatment of morbid obesity based on the complete method assessment;
  • Available evidence shows minor or no difference in weight loss, diabetes control, and health-related quality of life when using various surgical procedures for the treatment of morbid obesity;
  • Furthermore, it was not possible to determine the comparative effect of different surgical procedures on the risk of early mortality, progression of obesity, and obesity-related comorbidities;
  • The cost differences between the various surgical procedures used in Norway are non-significant;
  • Further high-quality research is needed to assess the comparative effectiveness of various surgical procedures for the treatment of morbid obesity.

See the full details in Norwegian here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

27

Jan 2023

On January 09, 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) published 2023 tariffs for the “low variability care” (APR-DRG) system. APR-DRG logic for 2023 is not published as of January 27, so no information about its changes or new DRGs is available.

Read more

26

Jan 2023

The updated German Uniform Evaluation Standard (EBM) catalog came into force on January 1, 2023. The EBM catalog (Einheitlicher Bewertungsmaßstab) regulates the reimbursement of services in the public outpatient sector in Germany and is updated once a quarter (four times a year). Among other changes, a new code for "zanadio" health app for follow-up and evaluation was introduced in the catalog.

Read more

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

23

Jan 2023

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

Read more